HMGB1 and infectious disease: Using several classes of known ICD inducers, including chemotherapeutic agents and existing infectious disease vaccines, we determined that in vitro treatment of both mouse and human TNBC cell lines with oxaliplatin or the seasonal influenza vaccine resulted in the highest levels of ICD biomarker exposure, including HMGB1, ATP and CRT.